It is estimated over 110 000 people are living with blood cancer or a related blood disorder in Australia today and sadly 15 people lose their life to blood cancer each day.
Mater Researchers are calling on people with intellectual disabilities and autism as well as their carers to participate in a program aimed at improving the way healthcare services are delivered.
Mater Researcher and clinician-scientist, Dr Joshua Tobin has been selected by the American Society of Hematology (ASH) to receive the 2021 ASH Global Research Award.
The Mater Inflammatory Bowel Disease (IBD) Research Group recently held their inaugural symposium to share novel research findings, and discuss innovation and the future of the group.
National Science Week runs from the 14 – 22 August in Australia and is an annual celebration of science, research, medicine and technology in this country.
Mater Research is calling for 50 adults in south-east Queensland to join the global clinical trial of a potential new protein-based COVID-19 vaccine, the latest vaccine trial being run at Mater...
Mater Research has shed new light on the role of the specialised immune cells osteal macrophages (osteomacs) in the often-debilitating bone degenerative disease osteoporosis.
National Science Week runs from the 14 – 22 August in Australia and is an annual celebration of science and technology in this country.
Congratulations to Mater Researcher Kristen Radford who has been promoted to Professor.
We continue National Science Week by celebrating more extraordinary women who are pushing the boundaries in science, research and medicine.
Dr Sahar Keshvari has been awarded the 2021Liver Foundation Professor Pauline Hall Fellowship to fund her potentially life-saving research into liver transplantation.